ACRIVON THERAPEUTICS INC
ACRV·004890109·US·Common Stock·Healthcare - Biotechnology-Activist
ACRV (ACRIVON THERAPEUTICS INC) is held by 33 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($11.6M), WELLINGTON MANAGEMENT GROUP LLP ($1.2M), RENAISSANCE TECHNOLOGIES LLC ($1.1M). Net institutional sentiment: Mixed.
33
Holders
(2 Elite)
$17.9M
Total Value
45% (33)
Consensus
15 buying - 18 selling
13F: Insider & Congress:
Who's Trading
InsiderBPBlume-Jensen PeterBuy $82KJan 14, 2026
InsiderLDLevy Adam D.Buy $15KJan 14, 2026
InsiderDEDevroe EricBuy $17KJan 13, 2026
ActivistSLSands Capital Life Sciences Pulse Fund II, L.P.6.8%Aug 13, 2025
ActivistPAPerceptive Advisors LLC0.0%Jun 4, 2025
InsiderPLPERCEPTIVE ADVISORS LLCSell $401KMay 1, 2025
InsiderPLPERCEPTIVE ADVISORS LLCSell $617KApr 30, 2025
InsiderPLPERCEPTIVE ADVISORS LLCSell $353KApr 29, 2025
Showing 1-20 of 41
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer